![Brian Daniels](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Daniels
Vorsitzender bei
ARTIVA BIOTHERAPEUTICS, INC.
Vermögen: - $ am 31.07.2026
Profil
Brian F.
Daniels is currently Chairman at Artiva Biotherapeutics, Inc. since 2020.
He is Director at RareCyte, Inc., Inipharm, Inc. since 2020, Transcelerate Biopharma, Inc., and Medarex, Inc. since 2009.
He is Independent Non-Executive Director at CSL Ltd. since 2024.
He serves as Advisor at Apexigen, Inc. and Venture Partner at 5AM Venture Management LLC since 2014.
Former roles include Non-Executive Director at Nohla Therapeutics, Inc., Independent Director at IDEAYA Biosciences, Inc., Director at Novo Nordisk Ltd., Spyryx Biosciences, Inc., and Armaron Bio Ltd. Independent Director at Novo Nordisk A from 2016 to 2021 and at Cabaletta Bio, Inc. from 2018 to 2021.
Principal at Merck Research Laboratories Massachusetts LLC and Genentech, Inc. Senior Advisor at The Boston Consulting Group from 2015 to 2018.
Senior Vice President-Global Development at Bristol Myers Squibb Co. from 2004 to 2014.
Education includes undergraduate and graduate degrees from Massachusetts Institute of Technology in 1981 and a doctorate from Washington University School of Medicine in 1987.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.07.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Brian Daniels
| Unternehmen | Position | Beginn |
|---|---|---|
| ARTIVA BIOTHERAPEUTICS, INC. | Vorsitzender | 01.06.2020 |
| APEXIGEN, INC. | Corporate Officer/Principal | - |
| CSL LIMITED | Direktor/Vorstandsmitglied | 01.12.2024 |
Inipharm, Inc.
 Inipharm, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that develops therapies for liver and related diseases | Direktor/Vorstandsmitglied | 11.11.2020 |
RareCyte, Inc.
 RareCyte, Inc. Medical SpecialtiesHealth Technology Develops life science research and diagnostic | Direktor/Vorstandsmitglied | - |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Private Equity Investor | 14.11.2014 |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Direktor/Vorstandsmitglied | - |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Direktor/Vorstandsmitglied | 13.05.2011 |
Ehemalige bekannte Positionen von Brian Daniels
| Unternehmen | Position | Ende |
|---|---|---|
| CABALETTA BIO, INC. | Direktor/Vorstandsmitglied | 24.06.2021 |
| ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Brian Daniels
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
21
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 21 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Spyryx Biosciences, Inc.
 Spyryx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for obstructive lung diseases | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Armaron Bio Ltd.
 Armaron Bio Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops cardioprotection and neuroprotection small molecules to reduce tissue damage for heart attacks | Electronic Technology |
RareCyte, Inc.
RareCyte, Inc. Medical SpecialtiesHealth Technology Develops life science research and diagnostic | Health Technology |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Nohla Therapeutics, Inc.
 Nohla Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular therapies for hematological disorders | Health Technology |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
The Boston Consulting Group | |
Cabaletta Bio, Inc.
 Cabaletta Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which discovers and develops engineered cell therapies for B cell-mediated autoimmune diseases | Health Technology |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Inipharm, Inc.
Inipharm, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that develops therapies for liver and related diseases | Health Technology |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
